chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever began early afternoon day after vaccine; Sweats; Shortness of breathe/labored breathing; Tight chest; Chills; Sore arm morning after vaccine; Nausea began in late morning the day after vaccine; This is a spontaneous report from a contactable consumer (patient).   A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: unknown) via an unspecified route of administration in the left arm on 17May2021 at 17:00 (at the age of 34-year-old) as a dose number unknown, single for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD), migraines, allergies, chronic stomach issues/irritable bowel syndrome (IBS) symptoms and possible allergy to latex. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received any other vaccines within four weeks prior to the vaccination. On 18May2021, the patient experienced sore arm morning after vaccine (Tuesday), nausea began in late morning the day after vaccine (Tuesday), fever began early afternoon day after vaccine (Tuesday at 15:00), chills, sweats, nausea persisted consistently for about 36 hours (through Thurs morning), fever broke but chills and nausea continued for remainder of day (Thursday). Tight chest/labored breathing when laying down to sleep for Tuesday and Thursday nights and still experiencing much quicker shortness of breath. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever was recovered on an unknown date in May2021. The clinical outcome of the events sore arm morning after vaccine, nausea, chills, sweats, tight chest, shortness of breathe/labored breathing was recovering at the time of this report.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
43 yo female received second dose of Moderna COVID-19 vaccine on 1/27 @1239. Approximately 10 minutes after administration, patient began experiencing lip tingling and sensation of itchiness in throat. Patient given cetirizine and famotidine without relief. Patient continued to report lip and tongue tingling/burning, dry cough, and sense of anxiety. Upon examination by physician, no tongue swelling, stridor, or wheezing observed. Mild erythema noted on chest, not neck. Diphenhydramine 25mg oral solution was administered and close monitoring continued including serial tongue examination and throat/lung auscultation. BP 138/82, HR 84. Approximately 5 minutes after the dose of diphenhydramine, noted a new sense of altered speech and shortness of breath. Tongue noted to be mildly edematous, increased as compared to prior exams, with clear view of oropharynx, still with no stridor or wheezes. Epinephrine pen 0.3 mg was administered to left thigh. EMS was called at this time as well, and 2L supplemental oxygen was administered. Noted improvement in symptoms after the epinephrine and tongue appearance returned to normal within about two minutes, speech normal. Continued to report feeling anxious. BP 143/80, HR 116 after epinephrine. EMS arrived and handoff given. Dexamethasone 8 mg, diphenhydramine 25 mg and lorazepam 0.5 mg given in the ED.  Patient eventually asymptomatic after 4 hours and discharged with EpiPen prescription @2051 that same day. Patient reported having urticarial and rash after her first vaccine. She has never had an anaphylactic reaction before, but did develop mucosal blisters with Bactrim and ciprofloxacin.
2 days after receiving my first dose of the Pfizer vaccine I experienced moderate pain in my lower right leg. I was uncertain where the pain came from (I did not injure myself, etc.) it took approximately a week, but the pain subsided. I received my 2nd dose, and again, 2 days later I just started experiencing the same pain in the same exact spot in my lower right area of my leg,
My injection site became very red, hot and itchy. It was 4 cm across. The full edematous area was 7 cm across. I was very tired the night before. Used Benadryl cream and one 50 mg capsule.
Burning sensation followed by numbness starting at the injection side (left)  going up to the left ear and left rear head.; Burning sensation followed by numbness starting at the injection side (left)  going up to the left ear and left rear head.; This is a spontaneous report from a non-contactable consumer (patient). A 43-year-old non pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on 15May2021 (at the age of 43-year-old) as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any medications within 2 weeks of vaccination and any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date in 2021, the patient experienced burning sensation followed by numbness starting at the injection side (left) going up to the left ear and left rear head, which resulted in doctor or other healthcare professional office/clinic visit. Patient stated it persisted for about 2.5 weeks after the first shot. The patient did not receive any treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
This is a spontaneous report from a contactable pharmacist. An 87-year-old male patient received the 1st dose of PREVNAR 13 (Lot# S58702, Exp date Aug2019, NDC 0005-1971-01), intramuscular in right arm, on 21Oct2017 at 12:20 PM, at 0.5 ml single, for immunisation. Relevant medical history included ongoing enlarged prostate, ongoing acid reflux (esophageal), blood disorder, sleep disorder. Concomitant medications included the 5th dose of FLUZONE on 21Oct2017 for immunisation, finasteride (unspecified trade name) from an unspecified date and ongoing for Enlarged prostate, tamsulosin (unspecified trade name) from an unspecified date and ongoing for enlarged prostate, omeprazole (unspecified trade name) from an unspecified date and ongoing for reflux, apixaban (ELIQUIS) from an unspecified date and ongoing for blood disorder, nortriptyline (unspecified trade name) from an unspecified date and ongoing for sleep disorder. Previously the patient received 4 doses of FLUZONE for immunisation, with no adverse effect. Patient got flu vaccine every year. The patient experienced arm hurting on 21Oct2017 at 12:20 PM with outcome of not recovered. The pharmacist reported that she thinks patient's arm is still sore from the needle stick, unknown if it is related to the actual vaccine or not. She thinks it's just muscle soreness the patient is still having. Patient complains his arm has been hurting since he received the vaccine. The event arm hurting was considered serious as per medically significant. Patient's doctor recommended ibuprofen and use compresses for arm hurting. Patient was unable to take ibuprofen so he took Tylenol.; Sender's Comments: A causal association between administration of PREVNAR 13 and the onset of event cannot be excluded, considering the temporal association and the known adverse event profile of the suspect product.
9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date; No adverse event; 9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date), EXPIRED PRODUCT ADMINISTERED (9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7168B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 14-Jan-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date), EXPIRED PRODUCT ADMINISTERED (9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date) and EXPIRED PRODUCT ADMINISTERED (9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date).    No relevant concomitant medications were reported.   Total 9 Patients received doses of the Moderna COVID19 vaccine bivalent after its beyond use date with lot number AS7168B. Vial size was 2.5mL. Date vial was initially stored in the fridge 14-Dec-2022.  Vaccine was administered on different dates. One dose was given on the 13-Jan-2023, 4 doses were given on 14-Jan-2023 one dose was given on 16-Jan-2023, one dose was given on 17-Jan-2023 and two doses were given on 19-Jan-2023. Vial did not undergone any temperature excursion issue  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-704964 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704964:Master case - 1st adult patient (vaccine start date: 13-Jan-2023)
Immediate mouth turning tight, tongue having slight swelling that resolved within 40 minutes. Nothing was reported to the pharmacy as I did not feel safe in their medical care after vaccine.  The day of vaccination complete memory loss that resolved by next morning. A few days after vaccine, Ive had a continuous nerve reaction occuring on my left upper should blade area ( same side vaccine was on) that has been the most bothersome.
pt recv vax 4AUG95 & MAY97 pt devel chickenpox of approx 100 lesions w/a low grade fever;
Patient left clinic at 2:46pm and went to office then car.  Returned to post vaccination area after feeling nauseous and "a little cold." Dr. completed assessment.  VSS while sitting in chair.  Allowed to rest, provided water.  Monitored for symptoms. Symptoms resolved at 4:28pm.  Pt picked up by family members in good condition.
Soreness at the injection site; Headache; Generally achy; Joint pain; Fatigue; sick; Cold; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 70-year-old female patient who received Herpes zoster (Shingrix) for an unknown indication.   On 8th November 2019, the patient received the 1st dose of Shingrix. In November 2019, less than a week after receiving Shingrix, the patient experienced injection site pain, headache, pain, arthralgia, fatigue, sickness and cold. On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the headache, pain, arthralgia, fatigue, sickness and cold were unknown.   The reporter considered the injection site pain, headache, pain, arthralgia, fatigue, sickness and cold to be possibly related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and had soreness at the injection site, but that was at the time of reporting gone. The patient had headache, joint pain and generally achy and fatigued. The patient thought it might be a cold but did not had any of those symptoms like congestion, sore throat, fever, just the aches and headache.
Dark under eye circles, extreme exhaustion, shortness of breath, rapid weight gain (20 lbs in a month), extreme facial swelling, confusion, and eventually leading to a Hypothyroid, Hoshimoto's and Graves Disease Diagnosis
tunnel vision; Drop in blood pressure and heart rate; Drop in blood pressure and heart rate; dizzy; nauseous; This is a spontaneous report from a contactable consumer (patient).  A 25-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered in arm left on 19Mar2021 12:45 (Batch/Lot Number: Ep6955) as SINGLE DOSE for COVID-19 immunization. The patient had no medical history and no known allergies. Concomitant medications were not reported. He had no COVID prior vaccination and not tested post vaccination. On 19Mar2021, the patient had drop in blood pressure and heart rate, tunnel vision, dizzy, and nauseous. The patient did not receive any treatment for the events. The patient recovered from the events in Mar2021.   No follow-up attempts are possible. No further information is expected.
Client presented for immunizations, and was due for Dtap #4, final Hib and PCV13, Hep A#1, MMR#1 and Varicella #1. I was training a nurse and she was pulling the vaccines and giving them to me and I wrote down the lot numbers and she gave the injections. I did not catch that one of the vaccines was MMRV instead of MMR until after the client left and I was entering the lot numbers. I contacted CDC who said there was no increased risk to the child, other than increased redness, itching or swelling at the site. I contacted the parent, and let them know what CDC said, and am completing the Vaers form. There had been no adverse event as of when I spoke to the mother on the phone about an hour afterwards.
My symptoms started on the 4th day after the injection of the first dose of my Covid-19 vaccine. It started with watery eyes, and itchy throat. The following day this developed into congestion and sore throat in addition to a fever, chills, body aches, and nausea.  All symptoms persisted for two more days except for a fever.
numbness around mouth; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA ORAL (numbness around mouth) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPOAESTHESIA ORAL (numbness around mouth). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Numbness mouth, at an unspecified dose and frequency. On 04-Mar-2021, HYPOAESTHESIA ORAL (numbness around mouth) had resolved.            Action taken with mRNA-1273 in response to the events was not applicable.  Concomitant medication was not reported.   This case was linked to MOD-2021-024471 (Patient Link).
HPI: Patient is a 63-year-old female with multiple medical problems who presents to the emergency department chief complaint of cough, abdominal pain, diarrhea, nausea, headache, back pain, and fevers.  Patient states that she has had her symptoms for approximately 9 days.  She was tested on 9/9 for COVID-19 and was negative.  Patient states that she has been having some diarrhea and vomiting but it temporarily improved
Event: Pain at injection site, dizziness, nausea. Treatment: Rest, Outcome: symptoms dissipated
Patient experienced left sided chest pain that started a few hours prior to getting his second dose of the covid vaccine on June 1, 2021.   Patient states the pain worsened after receiving his second dose of the vaccine.   He was admitted for a small pneumothorax on his left side.
(B) anterior thighs with flat macular rash approx 2 1/2-3cm diameter. No pain no papules no nodule no DIC.
The pt experienced an upper left arm with redness and swelling from shoulder to elbow and under arm to axilla. Treated with Benadryl.
Red, warm, swollen and sore arm. Dizziness, disoriented, fatigue, and exhaustion. Had difficulty raising his left arm.
patient then got 2 more primary series doses (18Jan2022 & 15Feb2022); This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (patient then got 2 more primary series doses (18Jan2022 & 15Feb2022)) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    In 2021, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2021, the patient experienced EXTRA DOSE ADMINISTERED (patient then got 2 more primary series doses (18Jan2022 & 15Feb2022)). At the time of the report, EXTRA DOSE ADMINISTERED (patient then got 2 more primary series doses (18Jan2022 & 15Feb2022)) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided.  No treatment medication were provided.  The patient had primary series doses, a 3rd dose for the immunocompromised, and a booster dose of the Moderna COVID-19 Vaccine. On an unknown date in Oct-2021, the patient then had a stem cell transplant for an unknown reason. The doctor recommended that she get all 4 doses again. The patient then got 2 more primary series doses (18-Jan-2022 and 15-Feb-2022).
Flu like symptoms increasing throughout the day. Fever, aches, chills, digestive upset
On 03/22 I noticed that my lymph nodes in my jaw neck area were swollen and tender. I took some echinacea and it helped to get the swelling down. In 07/22 the lymph nodes started swelling again, this time the echinacea did not help get the swelling to go down. I called my doctor's office and went in for a visit. They prescribed an antibiotic for me that helped to get the swelling to go down. This occurred again in 09/22, I called the doctor's office, this time we just had a telehealth visit and they called in an antibiotic prescription. My doctor did try to get me in for an ultrasound, but they were backed up and by the time they could get me in the swelling was down.
From telephone contact received at Aventis Pasteur Inc. on 09/05/2002, it was reported that an 18-year-old male was vaccinated on 09/04/2002 with Menomune A/C/Y/W-135 (lot# UB295AA).  On 09/05/2002, patient's parent called 911 after he collapsed.  Patient expired.  Autopsy is being performed.  Follow-up (#1) telephone call to the Coroner's Office on 09/17/2002:  "No information, no preliminary results" available at this time.  Investigator collected 7 doses of fluid and powder.  Toxicology results will take 8-12 weeks.  Family history positive for asthma.  Coroner's case number is 2002-02746.  From additional correspondence received at Aventis Pasteur Inc. on 02/12/2003, it was reported that the patient with no illnesses at time of vaccination and had no pre-existing diagnosis received first dose of MENOMUNE (expiration date 10/22/2003) subcutaneously in the left arm at 15:30 on 09/04/2002.  The patient was not responsive on 09/05/2002.  No cause of death was determined on the preliminary coroner's report on 09/06/2002.  As per the reporter, a copy of this report has been sent to VAERS on 09/09/2002.  Follow-up #2 correspondence received on 02/13/2003: From telephone contact to the Coroner's office, the toxicology was negative and the cause of death remains undetermined.  A copy of the autopsy has been requested.  Reported on 03/20/2003: "From follow-up #3 information received at Aventis Pasteur Inc. on 03/07/2003, it was reported that the decendant's Histological Examination from the autopsy report showed that the heart had few round cells in the epicardium, otherwise non-contributory.  Also, on histological exam the thyroid, spleen, kidney, lung, pancreas and the liver were all non-contributory.  All toxicology labs were negative.  The investigator's notes showed that the decendant had symptoms of the common cold about 3 months ago and was losing his hair, he was prescribed Propecia.  Autopsy on file: Case is closed.
Apnea requiring supplemental oxgyen and nasal CPAP, sepsis evaluation, starting of IV antibiotics, IV fluids, lethargy.
Fatigue/tiredness and ?brain fog? set in about 25 hours after vaccine (this was my second dose of the moderna Covid vaccine) . Brain fog has included trouble stringing thoughts together, using an incorrect word in a sentence, and also a strange ?giddy? feeling. Did not seek medical treatment. It is now April 26th at 10 PM, tiredness and brain fog continue.
Vaccinated at 11:50am. Developed blanket like raised red rash on chest approx 2x3 inches within first 15minutrs. Patient anxious stated maybe I?m having a panic attack, I?m sweating, but not visible. Continued observation. One Hive  developed on neck approx 12:20pm. Patient complained hands and feet very cold. Hands visibly dusky. Patient also claimed of feet and hand tingling. At 12:25pm BP 120/90. Reassurance observation is tachy 128. At 12:30pm BP remained at 120/90. Hive faded. Continued observation at 1:00pm. Given 50mg Benadryl and discharged to home where she continued under observation since she is my family member. Very anxious, very cold, no breathing difficulties at anytime. 20 min after Benadryl no signs of rash. Encouraged to rest.
Seen in office on 02/14/00 with bodily rash X 2 days, no scratching, some acute wheals and flare, comes and goes. had Trihibit + IPV on 02/07/00. Diagnosed as E multiforme with urticaria. Benadryl 12.5 mg as needed for itch
mild allergic reaction from the vaccine; This is a spontaneous report from a contactable consumer (patient).   A 54-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as UNKNOWN, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient is asking if it is okay to take Benadryl, she's having a mild allergic reaction from the vaccine. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot or batch number cannot be obtained.
I tested positive for COVID-19 in February 2023. I had congestion, sore throat, cough, body aches, and a bad headache. I contacted my doctor and was prescribed PAXLOIVD. I also took ibuprofen and SUDAFED. I am feeling much better now.
Severe muscular pain and stiffness in legs, arms, hands and neck.  Has been occurring (in 2021):  ? From late-April onward in legs. ? From mid-May onward in arms and legs. ? From late-May onward in neck, hands, arms and legs.  Occurs after being sedentary:  ? Especially severe in legs, arms, hands and neck upon waking each morning. ? Also severe in legs upon rising from being seated throughout each day.